Skip to main content
. 2013 Jan 17;5(1):94–106. doi: 10.3390/pharmaceutics5010094

Table 1.

Safety Boundary Using Blinded Data.

Number of Subjects
Number of Events SPRT TS
1 n.a. n.a.
2 2 ≤3
3 ≤11 ≤8
4 ≤20 ≤13
5 ≤28 ≤18
6 ≤37 ≤22
7 ≤46 ≤27
8 ≤55 ≤33
9 ≤63 ≤38
10 ≤72 ≤43